Why MiMedx Group, Inc.’s (MDXG) Stock Is Down 6.06%
As of Monday, November 02, MiMedx Group, Inc.’s MDXG share price has dipped by 6.06%, which has investors questioning if this is right time to buy.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Michael Rose
Rosalio Madrigal
Rosalio Madrigal
Cynthia McLaughlin
| Share Statistics | MDXG | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $453.8 | $212.8 | 38% |
|
| Shares Out (Mil) | 145.9 | 55.2 | 70% |
|
| Institutional Ownership | 96.7% | 93.3% | 70% |
|
| Float (Mil) | 107.6 | 40.8 | 61% |
|
| Beta | 1.17 | 1.03 | 69% |
|
| Avg Daily Volume (000s) | 1,403 | 559 | 75% |
|
| Price Change (52-week) |
(53.7%) | 40.3% | 19% |
|
| Growth | MDXG | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 11.0% | 13.6% | 62% |
|
| Net Income (5yr) | 24.5% | (10.5%) | 80% |
|
| EPS (5yr) | 19.3% | 15.4% | 67 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 10.9% | (15.7%) | 70% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 4 | 2 | |
| Current EPS | $0.010 | ($0.095) | $0.025 | |
| Month Ago EPS | $0.030 | ($0.077) | $0.105 | |
| # Rev Up | 0 | 1 | 1 | |
| # Rev Down | 1 | 0 | 0 | |
| Three Months Ago EPS | $0.040 | ($0.053) | $0.173 | |
| Year/Year Chg | (116.7%) | (129.7%) | (65.6%) | |
| Financials | MDXG | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $304 | $40 | 36% |
|
| Net Income (TTM) (Mil) | ($19) | ($44) | 24% |
|
| EPS (TTM) | ($0.130) | ($1.400) | 34% |
|
| Operating Cash Flow (TTM) (Mil) | $21 | ($34) | 41% |
|
| Net Cash Flow (TTM) (Mil) | ($21) | $-0 | 28% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | $459 | $142 | 34% |
|
| Valuation | MDXG | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.14 | 1.97 | 60% |
|
| P/E | na | 16.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.8 | na |
|
| Ratios | MDXG | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 77.3% | 67.6% | 87% |
|
| Net Margin | (6.3%) | (50.8%) | 23% |
|
| ROA | (6.6%) | (47.4%) | 27% |
|
| ROE | (8.5%) | (51.4%) | 28% |
|
| Liabilities to Assets | 20.2% | 29.6% | 13% |
|
| F-Score | 4 | 3 | 34% |
|
MiMedx Group, Inc. did not pass any screens on 11/19/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors